Equaline Redness Relief Lubricant Eye Drops

openFDA label record#

This page contains supplementary openFDA label data. For the canonical label presentation, use the corresponding DailyMed Structured Product Label.

Verified complete openFDA source JSON (canonical bytes are SHA-256 checked before publication)

Brand name
Equaline Redness Relief Lubricant Eye Drops
Generic name
GLYCERIN, NAPHAZOLINE HYDROCHLORIDE
Manufacturer
United Natural Foods, Inc
Product type
HUMAN OTC DRUG
SPL set ID
31a30b00-9f4b-717a-e063-6394a90a8a87
SPL ID
31a36709-1b78-e0d7-e063-6294a90a0a28
Version
2
Effective date
2024-01-01
Source export date
2026-10-27
Source partition
11
Source file
https://download.open.fda.gov/drug/label/drug-label-0011-of-0014.json.zip
Source object key
raw/openfda/drug-label/2026-10-27/b7a5e61d87a3b8f87f4c3ff7b526bfbf6baf84c840f565574c7d83d4083e2b38/drug-label-0011-of-0014.json.zip
Source manifest SHA-256
6be3667a3beefe6c0ead4c723ea963050533a2bc725a8044d58b07d18b258c55
Import run
20261027T193451Z
Imported at
2026-10-27 20:48:01
Harmonized routes table
Harmonized routes
OPHTHALMIC

Warnings cross-check#

openFDA text is shown for search and cross-checking; DailyMed SPL is canonical.

Warnings sections page 1 of 1 · 1 matching rows.

warnings

Warnings For external use only Do not use this product if solution changes color or becomes cloudy Ask a doctor before use if you have narrow angle glaucoma When using this product do not touch tip of container to any surface to avoid contamination replace cap after using overuse may cause more redness of the eye pupils may become enlarged temporarily Stop use and ask a doctor if you feel eye pain changes in vision occur redness or irritation of the eye lasts condition worsens symptoms last for more than 72 hours Keep out of reach of children. If swallowed, get medical help or contact a Poison Control Center (1800-222-1222) right away.

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.